-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On April 27, 2022, the team of Prof.
At present, SARS-CoV-2, especially the Omicron strain, is ravaging the world, and even co-infection with IAV appears, seriously endangering human public health
The author discusses the IAV that is currently relatively mature and is expected to become the most referenced IAV for SARS-CoV-2 research in addition to members of the Coronaviridae family, and strives to quickly establish a theoretical system for virus-host interaction.
It is worth noting that the game between host antiviral innate immunity and virus antagonism host innate immunity forms a virus-host interaction network
This review was supported by the National Key R&D Program (2021YFD1800205) and the National Natural Science Foundation of China (Grant No.
About the corresponding author:
Professor Ping Jihui has long been devoted to the research on the genetic evolution, pathogenicity, cross-host transmission and related molecular mechanisms of influenza virus, molecular basis of virus antigenic variation and prediction of antigenic variation, high-yield and high-efficiency influenza vaccine and has achieved a series of innovations.
Full text link:
https:// 1 Map of antiviral drug targets focusing on the IAV replication cycle
Figure 2 Map of antiviral drug targets focusing on the host's innate immune response against IAV
Figure 3 Map of antiviral drug targets focusing on the antagonistic effect of SARS-CoV-2 on the host innate immune signaling pathway
